KP-303

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameKP-303
Drug Alias NameKP-303
ClassificationOther
Mechanisms of ActionSerotonin 2a (5-HT2a) receptor antagonists
TargetsSerotonin 2a (5-HT2a) receptor
Therapy Area/IndicationsSchizophreniaDepressive Disorder, MajorBipolar Disorder
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesZevra Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesZevra Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSchizophreniaDepressive Disorder, MajorBipolar Disorder
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A